[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100460776":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":31,"centralContacts":36,"locations":42,"responsibleParty":60,"collaborators":10,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":10,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":10,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Far Eastern Memorial Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Tibolone",null,"Tibolone 2.5 mg per day",[13],"Drug: Tibolone 2.5 mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Indivina","Estradiol valerate (E2V) 1mg \\& medroxyprogesterone acetate 2.5 mg (MPA) per day",[18],"Drug: Estradiol valerate 1 mg\u002Fmedroxyprogesterone acetate 2.5 mg",[20,26],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","Tibolone 2.5 mg",[9],[25],"Livial",{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"Estradiol valerate 1 mg\u002Fmedroxyprogesterone acetate 2.5 mg","Estradiol valerate 1 mg\u002Fmedroxyprogesterone acetate 2.5 mg per day",[15],[15],[32],{"name":33,"affiliation":34,"role":35},"Sheng-Mou Hsiao, MD","Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital","PRINCIPAL_INVESTIGATOR",[37],{"name":33,"role":38,"phone":39,"phoneExt":40,"email":41},"CONTACT","+8868966700","1818","smhsiao2@gmail.com",[43],{"facility":34,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Banqiao District","New Taipei","22050","Taiwan","TW",{"type":51,"coordinates":52},"Point",[53,54],121.46719,25.01427,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":59,"phoneExt":40,"email":41},"Sheng-Mou Hsiao, M.D.","+886-2-89667000",{"type":35,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sheng-Mou Hsiao","Chief of Department of Obstetrics & Gynecology","100460776","hrt-on-overactive-bladder-symptoms-sexual-function-depressive-symptoms-autonomic-function-and-arterial-stiffness-100460776",false,"NCT05280028","HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness","The Impact of Different Hormone Therapy Regimens on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness","Inclusion Criteria:\n\n* \\>20 years old female\n* Menopausal symptoms, still have a uterus, and no breast or other cancers, and no vascular-blocking disease such as stroke.\n\nExclusion Criteria:\n\n* Nil.","FEMALE","20 Years",{"count":73,"type":74},100,"ESTIMATED","OBSERVATIONAL","Therefore, the aim of this study is to assess the therapeutic effect on overactive bladder symptoms, sexual function, heart rate variability, arterial stiffness, atherosclerosis, sleep, and depression between tibolone and E2V\u002FMPA.\n\nFrom the results, the investigators will compare the effect of tibolone versus E2V\u002FMPA on overactive bladder symptoms, sexual function, autonomic function, arterial stiffness, atherosclerosis, sleep and depression.",[78],"Menopausal Syndrome","2024-06-13",{"date":81,"type":82},"2024-06-17","ACTUAL",{"date":84,"type":82},"2022-02-07",{"date":86,"type":74},"2026-12-31",{"name":5,"class":6},1]